Keyword: Regeneron Pharmaceuticals
News
10.08.2021
-
US biotech Regeneron is planning to invest roughly $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at its Westchester...
News
31.03.2016
- Bayer and US drug developer Regeneron Pharmaceuticals have agreed to jointly develop a combination therapy of the angiopoietin2 (Ang2) antibody nesvacumab and vascular endothelial...
News
18.03.2016
- Drugmakers Regeneron Pharmaceuticals and Sanofi have said they will appeal a decision by a US federal jury that their cholesterol drug Praluent (alirocumab) infringes patents owned...
News
31.08.2015
- Amgen has won US Food and Drug Administration (FDA) approval for Repatha, the second medicine in a new class of biologics recently greenlighted by the agency and claimed to reduce...
News
16.09.2014
- Roche's cancer drug Avastin as a cheaper treatment for wet age-related macular degeneration (wAMD), a leading cause of blindness in the elderly, does not appear to increase deaths...
News
02.09.2014
- An experimental cholesterol-lowering drug, alirocumab, from Sanofi and Regeneron Pharmaceuticals roughly cut in half the number of heart attacks and strokes in a clinical trial...
News
14.01.2014
- Bayer HealthCare of Germany and its U.S. drug development partner Regeneron Pharmaceuticals have agreed to collaborate on Derived Growth Factor Receptor Beta (PDGFR-β) as a...
News
06.01.2014
- Bayer HealthCare has hit a stumbling block in the sales campaign for its new drug Eylea (aflibercept), or VEGF Trap-Eye, recommended for treatment of age-related wet macula...
